Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV-205 in Chronic Hepatitis C (Genotype 1) Non-Responders
NCT01058512Phase 2Completed
- Sponsor
- Cellectar Biosciences
- Start
- Mar 2010
- Primary completion
- Dec 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NOV-205 in hepatitis C (HCV), sponsored by Cellectar Biosciences. Started Mar 2010; status: completed.
02
Drugs
NOV-205
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01058512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01058512.